| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-07 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-07 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-07 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.21 | 5e-07 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-06 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |